Josh is a computational and medicinal chemist who has driven small-molecule programs from hit identification through lead optimization across a range of target classes and modalities. Prior to joining Inductive Bio, he was Associate Director of Chemistry, CADD at Delphia Therapeutics, where he was an early customer of Inductive Bio's platform and saw firsthand the impact it had on the team's design and triage work. He led structure-based design and QSAR modeling efforts at Delphia, and his previous programs have been licensed to Boehringer Ingelheim and Biogen. Josh earned his Ph.D. in Chemistry at Pennsylvania State University and completed his postdoctoral research at the University of Pittsburgh.